In the study, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) reduced the risk of radiographic progression or death by 59% ...

The FDA approved a radioligand therapy for earlier use prior to chemotherapy in patients with prostate-specific membrane ...

SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation ...

Symptoms of prostate cancer may include needing to urinate more frequently; having to rush to the toilet; straining to ...

A game-changing new type of radiation therapy cuts time while improving precision in targeting tumors, a development that ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, ...

Research reveals men skipping prostate cancer screenings are 45% more likely to die from the disease. Evidence from a large European study indicates P ...

Radiation therapy for prostate cancer can cause short-term side effects such as diarrhea, urine changes, and more. Long-term side effects such as urinary and bowel problems may also occur.

Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...